Cargando…
Bone Marrow Adiposity, Bone Mineral Density and Wnt/β-catenin Pathway Inhibitors Levels in Hemodialysis Patients
BACKGROUND: Marrow adipose tissue (MAT) is known to accumulate in patients with chronic kidney disease. This pilot study aimed to evaluate bone mineral density (BMD), MAT, visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT) using computed tomography (CT) scans and to explore correla...
Autores principales: | Wang, Yue-Pei, Khelifi, Nada, de Halleux, Cyrille, Ung, Roth-Visal, Samson, France, Gagnon, Claudia, Mac-Way, Fabrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Bone and Mineral Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208902/ https://www.ncbi.nlm.nih.gov/pubmed/35718928 http://dx.doi.org/10.11005/jbm.2022.29.2.113 |
Ejemplares similares
-
Role of the Wnt/β-Catenin Pathway in Renal Osteodystrophy
por: Bisson, Sarah-Kim, et al.
Publicado: (2018) -
Antihypertensive treatment with hydrochlorothiazide-hydralazine combination aggravates medial vascular calcification in CKD rats with mineral bone disorder
por: Larivière, Richard, et al.
Publicado: (2023) -
Division of an Iliac Crest Bone Biopsy Specimen to Allow Histomorphometry, Immunohistochemical, Molecular Analysis, and Tissue Banking: Technical Aspect and Applications
por: Picard, Sylvain, et al.
Publicado: (2020) -
Mineral and Bone Disease in Hemodialysis Patients
por: Theofilou, Paraskevi
Publicado: (2013) -
Catalpol promotes the osteogenic differentiation of bone marrow mesenchymal stem cells via the Wnt/β-catenin pathway
por: Zhu, Yu, et al.
Publicado: (2019)